MDMJ Shares Jump 179% After Earnings Beat

[Para 1: The Lead] On February 9, 2026, shares of MDJM (NASDAQ: MDJM) surged 179% in after-hours trading following the company's earnings report that beat analyst expectations by a significant margin. [Para 2-3: Supporting details & Context] The company reported fourth-quarter revenue of $487 million, a 23% increase from the prior-year period, and EPS of $1.26, exceeding the average estimate of $1.15. Management cited strong demand for its biologics and vaccines as the primary driver of the results. The stock closed at $24.12, up $19.60, on the day, reflecting investor confidence in the company's growth trajectory and strategic initiatives.